62089-34-3

Usage

Uses

Used in Pharmaceutical Synthesis:
3-Methoxy-5-methylbenzoic acid is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs with potential therapeutic benefits.
Used in Agrochemical Production:
In the agrochemical industry, 3-Methoxy-5-methylbenzoic acid is utilized as a building block in the creation of compounds that can enhance crop protection and management strategies.
Used in Fragrance and Flavoring Industry:
3-Methoxy-5-methylbenzoic acid is employed as a raw material in the production of fragrances and flavorings, capitalizing on its aromatic properties to create a variety of scents and tastes for consumer products.
Used in Anti-Inflammatory Research:
3-Methoxy-5-methylbenzoic acid is studied for its potential as an anti-inflammatory agent, aiming to develop treatments that can alleviate inflammation-related conditions.
Used in Anti-Cancer Research:
3-Methoxy-5-methylbenzoic acid is also being investigated for its anti-cancer properties, with the goal of identifying its potential to contribute to cancer treatment and management strategies.

InChI:InChI=1/C9H10O3/c1-6-3-7(9(10)11)5-8(4-6)12-2/h3-5H,1-2H3,(H,10,11)

Upstream product

• 126922-33-6 Ethyl 3-Methoxy-5-methylbenzoate 
• 585-81-9 3-hydroxy-5-methylbenzoic acid 
• 82477-66-5 1-chloro-3-methoxy-5-methylbenzene 
• 33719-74-3 3,5-dichloroanisole 
• 15719-64-9 methylammonium carbonate 
• 74-88-4 methyl iodide 
• 77-78-1 dimethyl sulfate 

Downstream Products

• 108593-44-8 methyl 3-methoxy-5-methylbenzoate 
• 96227-40-6 5-methoxy-3-methylbenzoic acid chloride 
• 124908-71-0 3-Methoxy-5-methyl-cyclohexa-2,5-dienecarboxylic acid 
• 119650-51-0 1-benzyloxy-10,12-dimethoxy-8-methyl-6H-benzo[d]naphtho[1,2-b]pyran-6-one 
• 126922-35-8 8-Benzyloxy-3-[2-(4,4-dimethyl-4,5-dihydro-oxazol-2-yl)-6-methoxy-4-methyl-phenyl]-4,4-dimethoxy-3,4-dihydro-2H-naphthalen-1-one 
• 119650-50-9 1-Benzyloxy-12-hydroxy-10-methoxy-8-methyl-dibenzo[c,h]chromen-6-one 
• 26448-96-4 2-ethyl-5-hydroxy-isophthalic acid 
• 28746-10-3 2-ethyl-5-methoxy-isophthalic acid 
• 1509919-74-7 3-methyl-5-[4-(morpholin-4-yl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]phenol 
• 1509920-02-8 2-(3-methoxy-5-methylphenyl)-4-(morpholin-4-yl)pyrido[3',2':4,5]furo[3,2-d]pyrimidine 
• 1509919-95-2 2-(3-methoxy-5-methylphenyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-4(3H)-one 
• 1509919-88-3 3-(3-methoxy-5-methylbenzamido)furo[2,3-b]pyridine-2-carboxamide 
• 1509919-81-6 ethyl 3-(3-methoxy-5-methylbenzamido)furo[2,3-b]pyridine-2-carboxylate 
• 1194258-61-1 C₁₅H₂₂O₅ 

Relevant academic research and scientific papers

DERIVATIVES OF 1 H-PYRAZOLO[3,4-B]PYRIDINE AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF PROLIFERATIVE DISORDERS

The present invention discloses compounds according to Formula (I): wherein R1, R2, R3, R4, L, and X are as defined herein. The present invention relates to compounds,methods for their production, pharmaceutical

NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF PROLIFERATIVE DISORDERS

The present invention discloses compounds according to Formula I: wherein R1, R2, R3, R4, L, and X are as defined herein. The present invention relates to compounds, methods for their production, pharmaceutical

Syntheses of fenanthroviridone, gilvocarcin BE-12406X2, and antibiotic WS 599B based on the palladium and copper catalyzed coupling of organostannanes with bromoquinones

A total synthesis of fenanthroviridone, gilvocarcin BE-12406X2, antibiotic WS 5995B is described based on the palladium and copper catalyzed coupling reaction of sterically hindered aryl stannanes with a 2-bromonaphthoquinone. Copyright (C) 199

Synthesis of antibiotics WS 5995 A and C and related compounds by palladium-catalyzed coupling of 2-bromonaphthoquinones with organostannanes

The synthesis of arylnaphthoquinones can be performed simply by using as the key reaction the Pd(0)- and Cu(I)-catalyzed coupling of arylstannanes with 2-bromonaphthoquinones as the electrophiles. The palladium-catalyzed coupling reaction is general and allows for the functionalization of the unprotected quinone nucleus with alkyl, alkenyl, and aryl substituents. The coupling process tolerates the presence of a chelated peri hydroxyl and steric crowding of a 2,6-disubstituted arylstannane, although the preparation of a 2,6,2',6'-tetrasubstituted biaryl by coupling of 2-bromo-3,5-bis(acetyloxy)-1,4-naphthoquinone as the electrophile with 2,6-disubstituted arylstannanes was unsuccessful. The syntheses of quinonoid antibiotics WS 5995 A and C was accomplished by using this method as the key step. Benz[b]phenanthridinone 1, hypothetical intermediate in the biosynthesis of benz[b]phenanthridine alkaloids, was also prepared from antibiotic WS 5995 C or by addition of ammonia to the 2-aryl-1,4-naphthoquinone 41 followed by heterocyclization.

A New Synthesis of Defucogilvocarcin M

A convergent synthesis of the title compound is described.The synthesis revolves around a MAD-mediated coupling of oxazoline 11 and naphthoquinone ketal 16 and requires eight steps via the longest linear sequence.

Synthesis of Antibiotic SS-228R. Strong Base Induced Cycloaddition of Homophthalic Anhydrides

Two types of naphthacenediones, 1,6,7-trihydroxy-9-methyl- (2) and 1,6,10-trihydroxy-8-methyl-naphthacene-5,12-diones (4), were prepared by the cycloaddition of 8-methoxy-6-methyl- (9) and 5-methoxy-7-methylhomophthalic anhydrides (10) with 2-bromojuglone